FDA Investigator Ross J Grigsby

Ross J Grigsby has inspections in 2 countries as of 13 Nov 2023. Ross J Grigsby has collaborated with a combinined 3233 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
48
Last Inspection Date:
13 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, India
Co-Investigator(s):
Aaron L Dunbar, Aimee J Edwin, Alan M Barker, Alicia M Mozzachio, Amos, Amy L Mcintyre, Ana M Placencia, Anastasia M Shields, Anthony J Ladner, April L Brown, April L Young, Ariel Cruz Figueroa, Arsen Karapetyan, Azza Talaat, Bei Y He, Benjamin W Anderson, Bichsa T Tran, Bijoy Panicker, Billi Jom Johnson, Blondell W Johnson, Bradley A Servais, Brian D Nicholson, Brian L Szcyubialka, Bruce H Mccullough, Carl A Huffman, III, Carolyn A Warren, Charles R Cote, RIC, Cheryl A Clausen, Christina L Bigham, Christopher D Leach, Constance L Richard, Constance Lrichard Math, Constantin Y Philopoulos, Courtney R Ingalsbe, Courtney R Tiegs, Dacia E Quick, Dale A Nyberg, Daniel J Roberts, David B Wieneke, David J Ward, David Perkins, Dawn E Barkans, Debra I Love, Demetria L Lueneburg, Denise L Burosh, Denise M Digiulio, Doan T Nguyen, PharmD, Duc Minh H Nguyen, Eboni S Funderburk, Edward A Fabiano, Edward M James, Elizabeth L Philpy, Emilie E Kahn, Eric S Myskowski, Fannie M Harrell, Felix Maldonado, Gina M Scholze, Greg A Abel, Gregory A Berg, Gregory S Larson, Gregory W Smith, Hasan A Irier, PhD, Heather Akleimola Hulbert, Howard A Burmester, Ivan E Reyes, Jacob G Luts, Jacob G Lutz, James A Beaulieu, James K Ireland, Janis R Armedoriz, Jeffery A Hangartner, Jeffry A Bernhardt, Jennifer Alongie Vollom, Jennifer S Ness, Jesse P Romenesko, Joel D Hustedt, Jon C Polzine, Jonathan G Gayechuway, Jonathan G Swoboda, Joseph A Piechocki, Joseph D Gong, Joseph M Edwin, Joshua M Adams, Justin A Boyd, Karen M Labounty, Karla J Youngberg, Kellia N Hicks, Kellie L Thommes, RN, Kellie L Westerbuhr, Kevin L Torgerson, Kevin P Regan, Kibily D Dembele, Krishna Ghosh, PhD, Krista K Petersen, Kristy E Zuroski, Kshitij A Patkar, Kyle J Mccracken, Larry K Austin, Lata C Mathew, PhD, Lauren E Sanger, Laurie A Haxel, Lequita M Mayhew, Lori B Wikstrom, M Edith Snyder, Mada A Tautges, Maf Maf, Margaret M Lubbers Solberg, Maria E Treadwell, Marie A Fadden, Marissa S Henning, Marissa S Steinhagen, Mark G Peterson, Matthew B Casale, Melanie C Voges, Melissa D Kalik, Melissa I Michurski, Michael C Zubelewicz, Michael E Cimaglio, Michele L Glendenning, Michele Perry Williams, Michelle J Glembin, Miguel A Martinez, Mohammed H Adam, Monica E Murie, Muralidhara B Gavini, PhD, Nicholas J Dubrovin, Nicholas P Diorio, Nicole C Victoria, PhD, Nicole E Knowlton, Patricia A Holmstrom, Patrick C Klotzbuecher, Peter T Erlandson, Phung Thien Nguyen, Pratik S Upadhyay, DDC, Rafael A Kaup, Ralph Jerndal, Ralph W Jemdal, Ramon A Hernandez, Rebecca L Caulfield, Rebecca Rodriguez, Richard Jay Tucker, RS, Rumany C Penn, PharmD, Russell K Riley, Samina S Khan, Sana A Elassar, Sandra A Hughes, Sandra D Wilson, Sandra D Wilson Newby, Sandra Sejdinovic, Santos E Camara, Sarah A Palmer, Scott A Golladay, Scott T Ballard, Sharon K Thoma, PharmD, Sharon L Matson, Simone E Pitts, Soyinka S Eneng, Stacie A Woods, State Agency, Steven D Kehoe, Susan D Yuscius, Susan M Atcher, Susan M Matthias, Susan P Bruederle, Tara M Carolfi, Theresa C Klaman, Thomas J Arista, Timothy R Marrs, Torrey M Ward, Toyin B Oladimeji, Victoria L Palmer, Walden H Lee, William P Fournier, Yasamin Ameri, Yiyue Zhang (nmi), PhD, Yoon K Oh, Yvonne E Lozano, Zhaoyang Meng

Ross J Grigsby's Documents

Publish Date Document Type Title
September, 2018 FDA 483 Response DIVERSIFIED MANUFACTURING CORP - Form 483R, 2018-10-16
December, 2021 FDA 483 McLaughlin Gormley King Company - Form 483, 2021-12-08
September, 2018 FDA 483 DIVERSIFIED MANUFACTURING CORP - Form 483, 2018-09-28
May, 2018 FDA 483 Medline Industries, LP (f/k/a Medline Industries, Inc.) - Form 483, 2018-05-22
February, 2022 FDA 483 Response Padagis US LLC - Form 483R, 2022-02-18
December, 2018 FDA 483 Upsher-Smith Laboratories, LLC - Form 483, 2018-12-19
April, 2019 EIR Fagron Inc - EIR, 2019-04-10
December, 2016 FDA 483 ProMed Pharma, LLC - Form 483, 2016-12-08
May, 2018 EIR Medline Industries, LP (f/k/a Medline Industries, Inc.) - EIR, 2018-05-22
September, 2018 FDA 483 Thrifty White Drug #762 - Form 483, 2018-09-21
July, 2018 FDA 483 Padagis US LLC - Form 483, 2018-07-31
May, 2018 FDA 483 Medline Industries, LP (f/k/a Medline Industries, Inc.) - Form 483, 2018-05-25
May, 2018 FDA 483 Response Medline Industries, LP (f/k/a Medline Industries, Inc.) - Form 483R, 2018-06-12
December, 2018 FDA 483 Upsher-Smith Laboratories, LLC - Form 483, 2018-12-19
February, 2022 EIR Padagis US LLC - EIR, 2022-02-18
August, 2021 FDA 483 IntegraDose Compounding Services LLC - Form 483, 2021-08-02
February, 2022 FDA 483 Padagis US LLC - Form 483, 2022-02-18
April, 2019 FDA 483 Fagron Inc - Form 483, 2019-04-10
February, 2019 FDA 483 Response Lifecore Biomedical, LLC - Form 483R, 2019-02-26
December, 2017 FDA 483 Fagron Inc - Form 483, 2017-12-21
February, 2019 FDA 483 Lifecore Biomedical, LLC - Form 483, 2019-03-22
April, 2022 EIR Rising Pharma Holdings, Inc. - EIR, 2022-04-08
September, 2019 FDA 483 Eco Lips, Inc. - Form 483, 2019-09-25
December, 2017 FDA 483 Response Fagron Inc - Form 483R, 2018-01-12
November, 2019 EIR Lifecore Biomedical, LLC - EIR, 2019-11-22
April, 2022 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2022-04-08
February, 2019 EIR Lifecore Biomedical, LLC - EIR, 2019-02-26
January, 2017 FDA 483 Athea Laboratories Inc - Form 483, 2017-01-25
December, 2018 FDA 483 Upsher-Smith Laboratories, LLC - Form 483, 2018-12-19
August, 2022 FDA 483 Upsher-Smith Laboratories, LLC - Form 483, 2022-08-30

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more